Condition: Castleman Disease · Castleman's Disease · Giant Lymph Node Hyperplasia · Sponsor: University of Pennsylvania
The purpose of this study is to collect clinical, laboratory, and patient survey data from patients with Castleman disease to improve understanding, diagnosis, and treatment of the disease. Funding source - FDA OOPD.
This description comes directly from the study's public registry record.
Joshua Brandstadter, MD, PhD, MSc · 267-847-8220 · joshua.brandstadter@pennmedicine.upenn.edu
Bridget Austin, MSc · 2675869977 · accelerate@uphs.upenn.edu
Always discuss trial participation with your own doctor first.
| University of Pennsylvania | Philadelphia, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02817997